NCT01778920View on ClinicalTrials.gov

Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA)

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2016

Study Completion Date

May 31, 2016

Conditions
Lung and Pleural MalignanciesNeoplasmsNodulesAdenocarcinoma
Interventions
DRUG

EC17 imaging contrast agent

This is an imaging agent to locate lung adenocarcinoma cancer cells during surgery

Trial Locations (2)

19104

Hospital of the University of Pennsylvania, Philadelphia

Philadelphia VA Medical Center, Philadelphia, PA, Philadelphia

All Listed Sponsors
collaborator

VA Office of Research and Development

FED

lead

University of Pennsylvania

OTHER

NCT01778920 - Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA) | Biotech Hunter | Biotech Hunter